Prophase Labs

Prophase Labs Diluted EPS

The Diluted Earnings per Share of Prophase Labs (PRPH) as of Oct 21, 2026 is -1.64 USD. In the previous year, Diluted Earnings per Share was -1.79 USD — a change of -7.95% (higher).

Diluted EPS

-1.64USD

YoY

-7.95%

Last updated:

Diluted Earnings per Share of Prophase Labs is 2025 -1.64 USD. Diluted Earnings per Share of Prophase Labs was 2024 -1.79 USD. It decreases by -7.95% higher compared to the previous year.

The Prophase Labs Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
-1.51 USD
Jan 1, 2019
-2.72 USD
Jan 1, 2020
-1.83 USD
Jan 1, 2021
4.06 USD
Jan 1, 2022
11.39 USD
Jan 1, 2023
-9.30 USD
Jan 1, 2024
-1.79 USD
Jan 1, 2025
-1.64 USD
The Prophase Labs Diluted EPS history
YEARDiluted EPSYoY
-1.64USD-7.95%
-1.79USD-80.79%
-9.30USD-181.66%
11.39USD+180.31%
4.06USD-321.87%
-1.83USD-32.58%
-2.72USD+80.41%
-1.51USD-105.70%
26.42USD-1,673.70%
-1.68USD+696.62%
-0.21USD-95.76%
-4.97USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Prophase Labs Stock analysis

What does Prophase Labs do? ProPhase Labs, Inc. generates revenue through the sale of over-the-counter consumer healthcare products and dietary supplements. The company develops and markets TK Supplements, featuring LEGENDZ XL for male sexual enhancement, TRIPLE EDGE XL for daily energy and stamina, and SUPER PROSTAFLOW plus for prostate and urinary health. ORXx Complete, a dietary supplement, and ORXx cough/cold drops are also sold to national wholesalers, distributors, and retail chains including pharmacies and mass merchandise stores. The firm targets health-conscious consumers seeking natural solutions through its OTC drug and supplement lines. Its products are distributed via national wholesalers and retailers such as independent and chain drugstores, food stores, and mass merchandise outlets. ProPhase Labs focuses on direct sales to these established retail segments without third-party branding or partnerships. Revenue streams are derived from the consistent demand for male enhancement, energy, and health supplements within the OTC market. The company's product portfolio caters specifically to customers interested in natural health products, with no additional services or digital platforms beyond physical product sales. Prophase Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Prophase Labs stock

Diluted Earnings per Share of Prophase Labs is -1.64 USD in 2025.

Diluted Earnings per Share of Prophase Labs changed from -1.79 USD to -1.64 USD, representing a -7.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Prophase Labs since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Prophase Labs

All Key Metrics — Prophase Labs